Anil Kumar Busimi - senior global product manager for SCHOTT iQ Platform at SCHOTT, explores how innovation in packaging is giving patients more options to administer medication from home.
Home delivery
The rise of biologics continues to dominate the global pharma drug pipeline, yet it is the administration of these drugs that presents a challenge to the pharma packaging. As biologics have become more structurally complex than their predecessors over the past decade, they require special packaging to ensure drug stability throughout shelf life.
More so, a changing market has introduced the possibility of home administration for biologics, which is being driven by the goal to lower healthcare costs. This is supported by advances in f primary packaging solutions. Medication now needs to be filled, stored and administered in a single container type, while at the same time allowing for easy, safe and accurate injection administration. This can be achieved with pre-filled syringes (PFS) but also by using auto-injectors and wearable devices.